Scapa Group PLC Trading Statement (2425T)
October 11 2017 - 1:00AM
UK Regulatory
TIDMSCPA
RNS Number : 2425T
Scapa Group PLC
11 October 2017
11 October 2017
Scapa Group plc ("Scapa" or "the Group")
Period end update
Scapa Group plc (AIM: SCPA), a global supplier of bonding
solutions and manufacturer of adhesive based products for the
Healthcare and Industrial markets, is today providing a period end
update for the six months ended 30 September 2017.
Group revenue, trading profits* and margins are all ahead of
last year. Results include the benefit from currency against the
equivalent period last year, and a full contribution from Euromed,
acquired in May 2016.
Healthcare sales grew 7.9%, or 2.1% at constant exchange rates,
with improvement in both trading profit and margins.
Industrial continues to benefit from the margin improvement
programs. During the period the Group successfully completed the
sale of the Rorschach property in Switzerland for CHF17.1m
(GBP13.6m), and acquired Markel Industries for US$10m
(GBP7.8m).
We remain confident of strong progress for the year, and we
anticipate the profit for the year will be ahead of current
expectations.
The Group will release its results for the half year on 21
November 2017.
*Before exceptional items, amortisation of intangible assets and
legacy pensions costs and finance charges
Enquiries:
Scapa Group plc
Heejae Chae - Chief Executive
Graham Hardcastle - Finance
Director 0161 301 7430
Numis Securities Limited
(Nominated Adviser)
Mark Lander / Richard
Thomas 020 7260 1000
Berenberg
(Joint Broker)
Chris Bowman 020 3207 7800
Weber Shandwick
Nick Oborne 020 7067 0721
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTOKKDKABDDOKD
(END) Dow Jones Newswires
October 11, 2017 02:00 ET (06:00 GMT)
Scapa (LSE:SCPA)
Historical Stock Chart
From Apr 2024 to May 2024
Scapa (LSE:SCPA)
Historical Stock Chart
From May 2023 to May 2024